Novo Nordisk A/S ADR buy Sanford C. Bernstein
Start price
09.09.25
/
50%
€45.85
Target price
09.09.26
-
Performance (%)
-12.98%
Price
06.08.26
€39.90
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -12.98%. This prediction currently runs until 09.09.26. The prediction end date can be changed by Sanford_C__Bernstein at any time. Sanford_C__Bernstein has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -10.818% | -10.818% |
| iShares Core DAX® | 1.842% | 1.387% |
| iShares Nasdaq 100 | 4.659% | -1.797% |
| iShares Nikkei 225® | 3.963% | -5.216% |
| iShares S&P 500 | 3.700% | 1.576% |
Comments by Sanford_C__Bernstein for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Sanford_C__Bernstein for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€32.60
18.03.26
18.03.26
€151.71
18.03.27
18.03.27
22.39%
06.08.26
06.08.26
